AOA 2025: Innovation and education take forefront at Optometry's Meeting
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
AOA 2025: Perfluorohexyloctane demonstrates early symptom relief and patient satisfaction
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
CIME 2025: What you missed in presbyopia tips, tricks, and updates
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO, provided their insights during CIME 2025 on May 4.
AAOpt: Presbyopia-correcting CSF-1 demonstrates consistent pupil restriction
CSF-1 (0.4% pilocarpine HCl), a presbyopia-correcting drop candidate from Orasis, demonstrated consistent pupil restriction, which also suggests neuroadaptation in patients with presbyopia to the drop over time.